LANDSCAPE CAPITAL MANAGEMENT, L.L.C.

Position in ABVX — Abivax S.A.

CIK 1536186 Englewood, NJ

Position in ABVX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$3,379,805

-$673,126 QoQ

Shares Held

30,353

+1.0% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

LANDSCAPE CAPITAL MANAGEMENT, L.L.C. holds $39,756,155 across 40 Biotechnology names. ABVX ranks #4 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	8,456	$4,426,460
2	HALO	Halozyme Therapeutics, Inc.	57,443	$3,712,540
3	EXEL	Exelixis, Inc.	84,956	$3,643,761
4	ABVX	Abivax S.A. This page	30,353	$3,379,805
5	REGN	Regeneron Pharmaceuticals, Inc.	3,935	$3,040,338
6	VKTX	Viking Therapeutics, Inc.	82,315	$2,678,529
7	NKTR	Nektar Therapeutics	36,907	$2,655,457
8	AXSM	Axsome Therapeutics, Inc.	14,129	$2,388,082

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,379,805	30,353	+1.0%	Shares	Defined	2026-05-12
2025-12-31	$4,052,931	30,054	—	Shares	Defined	2026-02-13
No filing history on record for this holder in this stock.